Search - tctmd.com

Displaying 641 - 660 of 725

Sort: Relevancy | Date

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

December 30, 2013

News Daily News

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

December 05, 2013

News Daily News

Warfarin Offers Poor Protection Against Radial Occlusion After Transradial Angiography

November 26, 2013

Presentation TCT 2013

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

Presenter: Harvey White

October 31, 2013

Presentation TCT 2013

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Presenter: Miroslava Stolcova

October 29, 2013

Presentation TCT 2013

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Presenter: Eugenia Nikolsky

October 28, 2013

News Conference News TCT 2013

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

October 28, 2013

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

Presentation TCT 2013

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Presenter: Michael Ezekowitz

October 27, 2013

News Daily News

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

October 04, 2013

News Daily News

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

Caitlin E. Cox

October 04, 2013

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Caitlin E. Cox

October 04, 2013

News Daily News

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

September 30, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Jason Kahn

August 12, 2013

News Daily News

Apixaban Benefits A-fib Patients Regardless of Previous Warfarin Use

Jason Kahn

August 06, 2013

News Daily News

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

Caitlin E. Cox

July 25, 2013

News Daily News

En Pacientes con FA, Aspirina + Anticoagulación Aumenta el Riesgo Hemorrágico

Caitlin E. Cox

July 25, 2013

Advertisement

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

Warfarin Offers Poor Protection Against Radial Occlusion After Transradial Angiography

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

Experts Discuss Efficacy, Safety of Watchman Device

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Apixaban Benefits A-fib Patients Regardless of Previous Warfarin Use

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

En Pacientes con FA, Aspirina + Anticoagulación Aumenta el Riesgo Hemorrágico

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content